Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial Malignancies. Jaeger-Ruckstuhl CA, Specht JM, Voutsinas JM, MacMillan HR, et al. Clin Cancer Res 2025;31:503-514.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jaeger-Ruckstuhl CA, Specht JM, Voutsinas JM, MacMillan HR, et al. Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial Malignancies. Clin Cancer Res 2025;31:503-514.
PMID: 39466024